32 studies found for:    Arnold-Chiari Malformation
Show Display Options
Rank Status Study
21 Completed
Has Results
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Condition: Healthy Volunteers
Intervention: Drug: Rotigotine transdermal patch
22 Completed
Has Results
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
23 Recruiting A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204 Formulation 1;   Drug: LEO 43204 Formulation 2;   Drug: LEO 43204 Formulation 1 Dose X;   Drug: LEO 43204 Formulation 1 Dose Y;   Drug: LEO 43204 Formulation 2 Dose XX;   Drug: LEO 43204 Formulation 2 Dose YY;   Drug: Placebo Formulation 1;   Drug: Placebo Formulation 2
24 Recruiting Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel;   Drug: placebo
25 Not yet recruiting Corneal Cross-Linking Comparing Variables
Condition: Unstable Corneas
Interventions: Drug: Epithelium-On Riboflavin;   Drug: Epithelium-Off Riboflavin;   Device: UV Light - Continuous Beam;   Device: UV Pulsed Beam
26 Completed A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
Condition: Actinic Keratoses
Intervention: Drug: PEP005
27 Recruiting Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions
Condition: Actinic Keratosis
Intervention: Drug: Ingenol mebutate
28 Completed Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: Ingenol once daily for two consecutive days
29 Completed Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005
Condition: Actinic Keratoses
Intervention: Drug: PEP005
30 Completed
Has Results
Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rotigotine;   Other: Placebo;   Drug: Moxifloxacin infusion;   Other: Placebo infusion
31 Completed
Has Results
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 5 cm^2 transdermal patch;   Drug: Rivastigmine 10 cm^2 transdermal patch
32 Recruiting Prenatal Surgical Repair of Fetal Myelomeningocele
Condition: Foetus With Myelomeningocele
Intervention: Procedure: prenatal surgical repair of fetal myelomeningocele

Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page
Indicates status has not been verified in more than two years